secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2021-08-23T23:59:59+00:00
Accession:  0001683168-21-003829
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PharmaCyte Biotech raises $70M in registered direct offering and private placement
--------------------------------------------------------------------------------

- Gross proceeds ~$70M from sale of 8.43M shares and 5.57M pre-funded warrants at $5.00 per share.
- Unregistered Series A warrants for 7M shares at $5.00, exercisable immediately, 5-year term.
- Net proceeds to address FDA clinical hold on IND for Phase 2b trial in pancreatic cancer and fund trial.
- H.C. Wainwright acting as exclusive placement agent; closing expected on or about August 23, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316821003829/0001683168-21-003829-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316821003829/pharmacyte_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-21-003829

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer